Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 141Unknown 22Terminated 21Recruiting 20Active not recruiting 7Not yet recruiting 5Withdrawn 3Suspended 2No longer available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 46Breast Neoplasms 46Colorectal Neoplasms 27Prostatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 21Leukemia, Myeloid, Acute 20Glioblastoma 19Melanoma 17Lung Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 16Glioma 14Stomach Neoplasms 13Ovarian Neoplasms 13Brain Neoplasms 13Carcinoma, Hepatocellular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Triple Negative Breast Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Carcinoma, Renal Cell 10Lymphoma 9Uterine Cervical Neoplasms 7Sarcoma 7Rectal Neoplasms 7Leukemia 7Hematologic Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7

Interventions

Ifosfamide 1Amblyomin-X protein, Amblyomma cajennense 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Advanced Cancer × Clear all
NCT03120130 2019-10-14

Amblyomin-X

União Química Farmacêutica Nacional S/A

Phase 1 Suspended
24 enrolled

Advanced Cancer

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡